Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Valves01:16

Heart Valves

14.7K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
14.7K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.3K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

468
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
468
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.3K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.3K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

913
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
913
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adiposity measures predict olfactory processing speed in older adult carriers of the apolipoprotein E ε4 allele.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2011
Same author

Evolution of sensory complexity recorded in a myxobacterial genome.

Proceedings of the National Academy of Sciences of the United States of America·2006
Same author

Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D.

International journal of immunopharmacology·2003
Same author

Chemotherapeutic stress mediated by certain antitumor antibiotics induces an atypical CD69+ surface phenotype in peripheral T-lymphocytes.

International immunopharmacology·2002
Same author

Midterm survival of stented versus stentless valves: does concomitant coronary artery bypass grafting impact survival?

Seminars in thoracic and cardiovascular surgery·2002
Same author

Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58.

Science (New York, N.Y.)·2001

Related Experiment Video

Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Early experience with stentless versus stented valves

G Cohen1, G T Christakis, K J Buth

  • 1Division of Cardiovascular Surgery, Sunnybrook Health Sciences Centre and The Toronto Hospital, University of Toronto, Ontario, Canada.

Circulation
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

The Toronto stentless porcine valve (SPV) showed improved ventricular function post-aortic valve replacement compared to stented valves (STD). However, no significant hemodynamic differences were observed between the SPV and STD groups in this study.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Related Experiment Videos

Last Updated: Apr 3, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

12.4K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

3.5K

Area of Science:

  • Cardiovascular Surgery
  • Biomaterials Science
  • Medical Devices

Background:

  • The Toronto stentless porcine valve (SPV) was developed to enhance hemodynamics in aortic valve replacement (AVR) by increasing flow area compared to traditional stented valves (STD).
  • Assessing hemodynamic performance is crucial for optimizing outcomes after AVR.

Purpose of the Study:

  • To prospectively compare the hemodynamic performance and ventricular remodeling between the Toronto stentless porcine valve (SPV) and stented valves (STD) after isolated aortic valve replacement.
  • To evaluate potential functional improvements in ventricular mechanics associated with SPV implantation.

Main Methods:

  • A prospective study involving 59 patients undergoing isolated AVR (+/- coronary artery bypass graft).
  • Patients received either a stented valve (STD, n=23) or the Toronto stentless porcine valve (SPV, n=36).
  • Preoperative and 3- to 6-month postoperative echocardiography were used to assess hemodynamic parameters and left ventricular mass index.

Main Results:

  • SPV implants were larger on average (26.6 mm vs. 24.0 mm, P=0.0002).
  • Postoperative effective orifice area increased significantly (P=0.0001), especially in the SPV group (1.9 cm2 vs. 1.5 cm2, P=0.01).
  • Ventricular function, measured by fractional shortening and velocity of circumferential shortening, improved significantly in SPV patients (P=0.0004 and P=0.0001, respectively).

Conclusions:

  • While SPV implantation was associated with improved ventricular function, no significant hemodynamic differences were detected between SPV and STD groups.
  • The non-randomized design may introduce selection bias, potentially influencing the observed results.
  • Further investigation through a prospective, randomized trial is warranted to definitively ascertain any hemodynamic advantages of the SPV.